Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey by Gattorno, M et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Pediatric Rheumatology
Open Access Poster presentation
Prevalence of monogenic autoinflammatory diseases among 
Pediatric Rheumatology centers: the Eurofever PReS/PRINTO 
survey
MG a t t o r n o * 1, J Frenkel2, S Ozen3, F De Benedetti4, I Konè-Paut5, N Neven6, 
H Girschick7, H Özdogan8, C Wouters9, P Woo10, M Hofer11, P Dolezalova12, 
N Toplak13, V Richard14, A Martini1 and N Ruperto1
Address: 1UO Pediatria II, Istituto Gaslini and Dipartimento di Pediatria, Università di Genova, Genova, Italy, 2University Medical Center, Utrecht, 
Utrecht, Italy, 3Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Bambino Gesù Pediatric Hospital, Roma, Italy, 5Centre Hospitalo-
Universitaire de Bicêtre, Le Kremlin Bicêtre, France, 6Hopital Necker-Enfants Malades, Paris, France, 7University of Würzburg, Würzburg, Germany, 
8University of Istanbul, Cerrahpa&#351;a Medical Faculty, Istanbul, Turkey, 9Universitair Ziekenhuis Leuven, Leuven, Belgium, 10University 
College London, London, UK, 11Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, 12Department of Paediatrics, Charles University, 
Prague, Czech Republic, 13Department of Rheumatology University Children's Hospital, Ljubljana, Slovenia and 14Faculty Children's Hospital 1st 
Department for Children and Adolescents, Kosice, Slovakia
* Corresponding author    
Background
Due to the rarity of Autoinflammatory diseases, affected
patients are usually seen in a number of different centers.
Aim of the study was to analyze the prevalence of the
autoinflammatory diseases followed by Centers of Pediat-
ric Rheumatology.
Methods
A secured web-based questionnaire on the number
patients with genetically defined or clinical suspected
Autoinflammatory disorders among the centers of Pediat-
ric Rheumatology members of the Pediatric Rheumatol-
ogy Trial International Organization (PRINTO, http://
www.printo.it) was performed.
Results
126 Centers from 38 Countries (94 in Europe, 13 South
America, 12 Asia, 5 Australia, 2 Africa) replayed to the sur-
vey. Among the patients with a genetic proven disease 73
were affected by TRAPS, 118 by HyperIgD syndrome, 153
by cryopyrinopathies, 71 by PAPA syndrome, 66 patients
by Blau's syndrome. A genetically proven FMF was
reported in 2484 patients (1947 from countries of the
Middle east and north Africa, 537 from other countries).
A number of patients with a clinical suspected Autoin-
flammatory were also reported: 68 with suspected TRAPS,
84 HyperIgD, 57 cryopyrinopathies, 50 PAPA, 60 Blau's
syndrome. The ratio between genetically proven vs sus-
pected disease was 1.97 in Western European countries
and 0.6 in Countries where the molecular analysis is not
available.
Conclusion
A relevant number of patients with genetically defined or
clinical suspected Autoinflammatory diseases are fol-
lowed by different Centers of Pediatric Rheumatology
worldwide. A network of registries for the proper collec-
tion of data coming from these patients and an improve-
ment of the possibilities for the molecular diagnosis in
non-Western European Countries are recommended.
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